Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach

Aflatoxin B1 (AFB1) is a mycotoxin produced by several species of Aspergillus fungi that can induce liver cancer in animals and humans upon ingestion of AFB1-contaminated food. This study aims to perform the risk assessment of AFB1 in herbal medicines and plant food supplements (PFS) marketed in...

Full description

Saved in:

Bibliographic Details
Main Author:	Ab Dullah, Siti Soleha
Format:	Thesis
Language:	English
Published:	2022
Subjects:	Aflatoxin B1 - adverse effects (AE) Plant Extracts Dietary Supplements
Online Access:	http://psasir.upm.edu.my/id/eprint/103865/1/SITI%20SOLEHA%20BINTI%20AB%20DULLAH%20-%20IR.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-upm-ir.103865
record_format	uketd_dc
spelling	my-upm-ir.1038652023-05-22T04:10:10Z Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach 2022-02 Ab Dullah, Siti Soleha Aflatoxin B1 (AFB1) is a mycotoxin produced by several species of Aspergillus fungi that can induce liver cancer in animals and humans upon ingestion of AFB1-contaminated food. This study aims to perform the risk assessment of AFB1 in herbal medicines and plant food supplements (PFS) marketed in Malaysia through the margin of exposure (MOE) approach. A total of 31 herbal medicines and PFS samples were purchased through online platforms and over-the-counter using targeted sampling method. Samples extracted with 70% methanol were subjected to immunoaffinity column filtration and quantified using ELISA assay. Next, the MOE was calculated using the benchmark dose lower level of 10 (BMDL10) of 63.46 ng/kg bw/day derived from the animal carcinogenicity data, and the estimated daily intake (EDI) among Malaysian adults ranged from 0.006 to 10.456 ng/kg bw/day. MOE below 10, 000 indicate the urgency for risk management actions. The estimated percentage of liver cancer attributable to AFB1 exposure was calculated by dividing the target population risk per year per 100,000 population by the agestandardised incidence rate for liver cancer. AFB1 was detected in 80.6% of samples analysed at a level ranging from 0.275 to 13.941 μg/kg. The calculated MOE ranged from 6.07 to 10227.35. In total, 24 (96%) out of 25 positive samples had MOE below 10,000. The risk of liver cancer ranged from 0 to 0.261 cancers per 100,000 population per year and the estimated percentage of liver cancer incidence ranged from 0.002% to 4.149%. This study found a moderate risk of liver cancer in Malaysian populations due to AFB1 from herbal medication and PFS, emphasising the need for risk management measures. Aflatoxin B1 - adverse effects (AE) Plant Extracts Dietary Supplements 2022-02 Thesis http://psasir.upm.edu.my/id/eprint/103865/ http://psasir.upm.edu.my/id/eprint/103865/1/SITI%20SOLEHA%20BINTI%20AB%20DULLAH%20-%20IR.pdf text en public masters Universiti Putra Malaysia Aflatoxin B1 - adverse effects (AE) Plant Extracts Dietary Supplements Abdullah, Rozaini
institution	Universiti Putra Malaysia
collection	PSAS Institutional Repository
language	English
advisor	Abdullah, Rozaini
topic	Aflatoxin B1 - adverse effects (AE) Plant Extracts Dietary Supplements
spellingShingle	Aflatoxin B1 - adverse effects (AE) Plant Extracts Dietary Supplements Ab Dullah, Siti Soleha Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
description	Aflatoxin B1 (AFB1) is a mycotoxin produced by several species of Aspergillus fungi that can induce liver cancer in animals and humans upon ingestion of AFB1-contaminated food. This study aims to perform the risk assessment of AFB1 in herbal medicines and plant food supplements (PFS) marketed in Malaysia through the margin of exposure (MOE) approach. A total of 31 herbal medicines and PFS samples were purchased through online platforms and over-the-counter using targeted sampling method. Samples extracted with 70% methanol were subjected to immunoaffinity column filtration and quantified using ELISA assay. Next, the MOE was calculated using the benchmark dose lower level of 10 (BMDL10) of 63.46 ng/kg bw/day derived from the animal carcinogenicity data, and the estimated daily intake (EDI) among Malaysian adults ranged from 0.006 to 10.456 ng/kg bw/day. MOE below 10, 000 indicate the urgency for risk management actions. The estimated percentage of liver cancer attributable to AFB1 exposure was calculated by dividing the target population risk per year per 100,000 population by the agestandardised incidence rate for liver cancer. AFB1 was detected in 80.6% of samples analysed at a level ranging from 0.275 to 13.941 μg/kg. The calculated MOE ranged from 6.07 to 10227.35. In total, 24 (96%) out of 25 positive samples had MOE below 10,000. The risk of liver cancer ranged from 0 to 0.261 cancers per 100,000 population per year and the estimated percentage of liver cancer incidence ranged from 0.002% to 4.149%. This study found a moderate risk of liver cancer in Malaysian populations due to AFB1 from herbal medication and PFS, emphasising the need for risk management measures.
format	Thesis
qualification_level	Master's degree
author	Ab Dullah, Siti Soleha
author_facet	Ab Dullah, Siti Soleha
author_sort	Ab Dullah, Siti Soleha
title	Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
title_short	Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
title_full	Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
title_fullStr	Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
title_full_unstemmed	Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach
title_sort	risk assessment of aflatoxin b1 in herbal medicines and plant food supplements marketed in malaysia through margin of exposure approach
granting_institution	Universiti Putra Malaysia
publishDate	2022
url	http://psasir.upm.edu.my/id/eprint/103865/1/SITI%20SOLEHA%20BINTI%20AB%20DULLAH%20-%20IR.pdf
_version_	1776100377046810624

Risk assessment of aflatoxin B1 in herbal medicines and plant food supplements marketed in Malaysia through margin of exposure approach

Similar Items